Edgardo Baracchini
Director/Board Member chez 4D PHARMA PLC
Fortune : - $ au 31/03/2024
Profil
Edgardo Baracchini is currently the Chairman at CoImmune, Inc., an Independent Non-Executive Director at 4D Pharma Plc, an Independent Director at INmune Bio, Inc., and the Principal at Baracchini Consulting LLC.
Previously, he held positions such as Director-Business Development at Agouron Pharmaceuticals LLC, Assistant Director-Business Development at Ionis Pharmaceuticals, Inc., Vice President-Business Development at Elitra Pharmaceuticals, Inc., Senior Vice President-Business Development at Metabasis Therapeutics, Inc., and Chief Business Officer at Xencor, Inc. He also served as the Chief Business Officer at Imago BioSciences, Inc. from 2020 to 2021.
Dr. Baracchini obtained his undergraduate degree from the University of Notre Dame, a doctorate from The University of Texas at Dallas, and an MBA from the University of California Irvine School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
INMUNE BIO, INC.
-.--% | 17/04/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Edgardo Baracchini
| Sociétés | Poste | Début |
|---|---|---|
| 4D PHARMA PLC | Director/Board Member | 08/09/2019 |
| INMUNE BIO, INC. | Director/Board Member | 08/08/2019 |
CoImmune, Inc.
 CoImmune, Inc. Pharmaceuticals: MajorHealth Technology CoImmune, Inc. engages in manufacture and development of cell-based therapeutics. It offers warehouse management, processing suites, logistics, research labs, and qualification and validation. The company was founded in February 2019 and is headquartered in Durham, NC. | Chairman | 15/11/2021 |
| Baracchini Consulting LLC | Corporate Officer/Principal | 01/01/2019 |
Anciens postes connus de Edgardo Baracchini
| Sociétés | Poste | Fin |
|---|---|---|
| IMAGO BIOSCIENCES, INC. | Corporate Officer/Principal | 01/02/2021 |
| XENCOR, INC. | Corporate Officer/Principal | 15/08/2018 |
Metabasis Therapeutics, Inc.
 Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | Corporate Officer/Principal | 23/10/2009 |
Elitra Pharmaceuticals, Inc.
 Elitra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Elitra Pharmaceuticals, Inc. used to develop pharmaceutical products. The company employed proprietary methods for gene analysis and anti-microbial drug discovery. It used to develop technology to miniaturize anti-microbial drug screens. It was also engaged in the identification, development and commercialization of novel antimicrobial compounds that target essential gene products of pathogenic organisms. The company was founded in 1997 and was headquartered in San Diego, CA | Corporate Officer/Principal | 02/01/2002 |
Agouron Pharmaceuticals LLC
 Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Agouron Pharmaceuticals LLC develops and distributes therapeutic products. It provides therapeutic products which are used in the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, pharmaceutical preparations and other diseases. The company was founded in 1984 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01/01/1999 |
Formation de Edgardo Baracchini
| University of Notre Dame | Undergraduate Degree |
| The University of Texas at Dallas | Doctorate Degree |
| University of California Irvine School of Medicine | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| IONIS PHARMACEUTICALS, INC. | Health Technology |
| XENCOR, INC. | Health Technology |
| 4D PHARMA PLC | Health Technology |
| INMUNE BIO, INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
Agouron Pharmaceuticals LLC
Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Agouron Pharmaceuticals LLC develops and distributes therapeutic products. It provides therapeutic products which are used in the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, pharmaceutical preparations and other diseases. The company was founded in 1984 and is headquartered in San Diego, CA. | Health Technology |
Elitra Pharmaceuticals, Inc.
Elitra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Elitra Pharmaceuticals, Inc. used to develop pharmaceutical products. The company employed proprietary methods for gene analysis and anti-microbial drug discovery. It used to develop technology to miniaturize anti-microbial drug screens. It was also engaged in the identification, development and commercialization of novel antimicrobial compounds that target essential gene products of pathogenic organisms. The company was founded in 1997 and was headquartered in San Diego, CA | Health Technology |
Metabasis Therapeutics, Inc.
Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | Health Technology |
Imago BioSciences, Inc.
 Imago BioSciences, Inc. BiotechnologyHealth Technology Imago BioSciences, Inc. operates as a clinical-stage biopharmaceutical company that develops novel anti-cancer therapeutics. It translates science of genetics and epigenetics enzymes into novel medicines for treating myeloid diseases that pose challenges to patients, families, and physicians. The company also translates insights into transformative therapies that alter the history of disease allowing patients to live longer and disease-free lives. Imago BioSciences was founded by Hugh Young Rienhoff, Jr., Laura G. Eichorn and Jennifer Peppe on March 29, 2012 and is headquartered in Redwood City, CA. | Health Technology |
CoImmune, Inc.
CoImmune, Inc. Pharmaceuticals: MajorHealth Technology CoImmune, Inc. engages in manufacture and development of cell-based therapeutics. It offers warehouse management, processing suites, logistics, research labs, and qualification and validation. The company was founded in February 2019 and is headquartered in Durham, NC. | Health Technology |
| Baracchini Consulting LLC |
